Workflow
CROSSJECT announces initiation of coverage of its stock by Portzamparc (BNP Paribas Group)
Globenewswire· 2026-02-02 06:15
* This project has been supported in whole or in part with federal funds from the US Department of Health and Human Services; Administration for Strategic Preparedness and Response; BARDA, under contract number 75A50122C00031. Attachment CROSSJECT announces initiation of coverage of its stock by Portzamparc (BNP Paribas Group) - Alpha Value - Invest Securities - Maxim Group - Oddo - Portzamparc (BNP Paribas Group) CROSSJECT announces initiation of coverage of its stock by Portzamparc (BNP Paribas Group) DIJ ...
VGP NV: Voting Rights and Denominator
Globenewswire· 2026-02-02 06:00
Core Insights - VGP has disclosed its total share capital and voting rights as of January 31, 2026, with a total share capital of €136,091,705.08 and a total of 42,987,703 voting rights [2] Group 1: Share Capital and Voting Rights - The total number of securities with voting rights is 27,291,312, while the number of securities with double voting rights is 15,695,945 [2] - The total number of voting rights, which serves as the denominator for the notification of major shareholdings, is 42,987,703 [2] Group 2: Double Voting Rights - Fully paid-up registered shares that have been held by the same shareholder for at least two consecutive years grant double voting rights, while dematerialised shares do not [3] - VGP uses the LIFO method to calculate the holding period for double voting rights, meaning the most recently acquired shares are the first to be deducted if shares are transferred [3] - It is crucial for VGP to be informed of any transfer of registered shares to maintain an accurate register of shares with double voting rights [3] Group 3: Company Overview - VGP is a pan-European owner, manager, and developer of logistics and semi-industrial properties, as well as a provider of renewable energy solutions [4] - Founded in 1998, VGP operates in 18 European countries with approximately 412 full-time employees and has a Gross Asset Value of €8.3 billion as of June 2025 [4] - The company's Net Asset Value (EPRA NTA) is reported at €2.6 billion, and VGP is listed on Euronext Brussels [4]
EfTEN United Property Fund unaudited financial results for 4th quarter and 12 months of 2025
Globenewswire· 2026-02-02 06:00
Financial Performance - In 2025, EfTEN United Property Fund achieved its highest net profit to date, amounting to 3.57 million euros, which is a 2.2 times increase compared to 2024's profit of 1.62 million euros, representing approximately 14% of the Fund's invested capital and around 17% of its market capitalization [1] - The Fund's revenues rose from 1.82 million euros in 2024 to 3.78 million euros in 2025, indicating significant growth [1] - The Fund distributed over 9% of its market capitalization to investors in 2025 [1] Portfolio Highlights - The improved profitability of the Uus-Järveküla residential development and the acquisition of Kristiine Shopping Centre contributed significantly to the Fund's financial performance [2] - By the end of 2025, all completed semi-detached and terraced houses in the Uus-Järveküla area had been sold, with the final stage of development, consisting of 32 terraced houses, planned for completion in spring 2026, of which 20 have already been booked [2] Kristiine Shopping Centre Performance - Visitor numbers to Kristiine Shopping Centre increased by 0.4% in 2025, reaching 6 million, while tenant sales grew by 5.4% year-on-year [3] - The net rental income exceeded budgeted forecasts by 4%, and the centre had no vacant rental premises at the end of December [3] Revaluation Impact - The Fund's financial performance in December was positively influenced by the regular revaluation of its real estate portfolio, resulting in a fourth-quarter profit of 1.46 million euros, largely due to the increase in the value of its subsidiary, Invego Uus-Järveküla OÜ [4] Cash Flow and Distributions - All investments in rental real estate generated positive cash flow in 2025, with expected distributions of approximately 800,000 euros from the 2025 investment results of the underlying funds, nearly double the amount from spring 2025 [5] - Additional distributions from the Uus-Järveküla development are anticipated, amounting to approximately 100,000 euros, to be distributed to investors during 2026 [5] Comprehensive Income Statement - For the 12 months of 2025, total income reached 3.78 million euros, up from 1.82 million euros in 2024, with a net profit of 3.57 million euros compared to 1.62 million euros in the previous year [6] - The ordinary and diluted profit per unit increased to 1.44 euros in 2025 from 0.65 euros in 2024 [6] Asset Overview - As of December 31, 2025, total assets amounted to 29.21 million euros, an increase from 27.89 million euros in 2024 [7] - The net asset value of the Fund attributable to unitholders was 29.21 million euros, up from 27.48 million euros in the previous year [7]
Press Release: Sanofi’s venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher disease
Globenewswire· 2026-02-02 06:00
Core Insights - Sanofi's investigational drug venglustat has shown positive results in a phase 3 study for type 3 Gaucher disease, meeting all primary endpoints and three out of four key secondary endpoints [1][4][8] Group 1: Study Results - The LEAP2MONO phase 3 study demonstrated that patients receiving venglustat had statistically significant improvements in neurological symptoms compared to those receiving enzyme replacement therapy (ERT), with a p-value of 0.007 [4][8] - Venglustat showed comparable efficacy to ERT in non-neurological outcomes, including changes in spleen volume, liver volume, and hemoglobin levels [4][8] - The study involved 43 patients aged 12 and older, randomized to receive either venglustat or ERT, with a focus on neurological assessments over 52 weeks [13] Group 2: Drug Mechanism and Background - Venglustat is a glucosylceramide synthase inhibitor designed to reduce the accumulation of harmful sugar-and-fat molecules in cells, specifically targeting neurological aspects of Gaucher disease that lack approved therapies [2][12] - Gaucher disease is a rare lysosomal storage disorder characterized by the accumulation of glycosphingolipids, leading to various systemic and neurological symptoms [10] Group 3: Future Plans and Regulatory Path - Sanofi plans to pursue global regulatory filings for venglustat in treating type 3 Gaucher disease [7][8] - The company has a long-standing commitment to rare disease research and has supported the Gaucher disease community for over 40 years [2][4] Group 4: Safety and Tolerability - Venglustat was well tolerated in the study, with no new safety signals reported compared to previous studies; common adverse events included headache, nausea, spleen enlargement, and diarrhea [6][8]
Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026
Globenewswire· 2026-02-02 06:00
Core Insights - Molecular Partners AG has presented promising first patient imaging and dosimetry data for its DLL3-targeted Radio-DARPin candidate MP0712 at the 8th Theranostics World Congress, indicating strong potential for treating small cell lung cancer and other DLL3-expressing neuroendocrine cancers [1][2][4] Clinical Development - The data from five evaluable patients show favorable tumor uptake of MP0712 with limited uptake in healthy tissues, supporting its therapeutic potential [2][3] - The biodistribution and dosimetry data validate the ongoing U.S. Phase 1/2a study of MP0712, which aims to assess safety and determine a recommended phase 2 dose [4][5] Presentation Details - Two posters and an oral presentation were made at the congress, highlighting the specific tumor accumulation and dosimetry data that support the clinical development of MP0712 [5][7] - The oral presentation titled "From DARPins to Radio-DARPin Therapeutics" was scheduled for January 31, 2026, focusing on the progress of MP0712 [7] Future Outlook - Initial clinical data from the Phase 1/2a study of MP0712 is expected in 2026, with the company planning to share safety and activity data as the study progresses [4][5] - The company aims to establish itself as a leader in alpha-targeted therapies for small cell lung cancer and neuroendocrine malignancies [4]
SOUEAST's Newest S08 DM To Make UAE Debut at Dubai Fashion Week
Globenewswire· 2026-02-02 05:39
Core Insights - SOUEAST is launching its new model, the S08 DM, at Dubai Fashion Week, marking its entry into the UAE market [1] - The S08 DM is a 7-Seat Urban Comfort SUV with a design that merges automotive and fashion aesthetics [3] Group 1: Product Features - The S08 DM features a "Mountain and Sea Symbiosis Aesthetic Design" with a wide-body and luxurious silhouette [3] - It includes Stellar Panoramic Headlights and a Wave-patterned Horizontal Grille, enhancing its stylish appeal [3] - The vehicle offers 5 exterior color options and 2 interior color schemes for personalization [3] Group 2: Strategic Partnership - SOUEAST is the official automotive partner for Dubai Fashion Week, reinforcing its brand presence in the Middle East [4] - This partnership allows SOUEAST to showcase its design philosophy and engage with a broader audience through fashion [4]
Mowi ASA (OSE:MOWI): Presentation of Q4 2025 results 11 February 2026 at 08:00 (CET)
Globenewswire· 2026-02-02 05:30
Group 1 - Mowi ASA will present the results for the fourth quarter of 2025 at The Salmon, Oslo, Norway [1] - The presentation will be conducted in English via a live webcast, followed by a Q&A session where participants can submit questions online [1] - A recording of the webcast will be available on the company's website immediately after the presentation [1] Group 2 - The quarterly report and presentation will be published at 06:30 (CET) [2] - This information is in compliance with the disclosure requirements of the Norwegian Securities Trading Act [2]
Apollo Silver Accepted into U.S. Defense Industrial Base Consortium
Globenewswire· 2026-02-02 05:00
Core Viewpoint - Apollo Silver Corp. has been accepted into the U.S. Defense Industrial Base Consortium (DIBC), highlighting the strategic importance of U.S.-based critical mineral assets, particularly silver, barite, and zinc, in supporting national security and defense priorities [5][4]. Company Overview - Apollo Silver is advancing one of the largest undeveloped primary silver projects in the U.S., the Calico Project, which contains significant silver mineralization along with barite and zinc, classified as critical minerals essential for various industrial and defense applications [3][6]. - The company also holds an option on the Cinco de Mayo Project in Mexico, which features a major high-grade carbonate replacement deposit [6]. Industry Context - The DIBC focuses on enhancing the resilience and security of domestic critical mineral supply chains, which are vital for U.S. defense and industrial applications [2]. - Membership in the DIBC allows Apollo Silver to engage in federally sponsored initiatives related to the mining and processing of critical minerals, aligning with U.S. priorities on supply-chain security and industrial resilience [4][5].
FireFly to unlock value from Pickle Crow Gold Project by sale for up to A$86.1M
Globenewswire· 2026-02-01 23:07
Core Viewpoint - FireFly Metals Ltd has entered into a binding share sale and purchase agreement with Bellavista Resources Ltd to sell its Ontario Gold Assets, which include a 70% interest in the Pickle Crow Project and 100% of the Sioux Lookout Project, for a total consideration valued at up to A$86.1 million, providing ongoing exposure to the assets for FireFly shareholders while allowing FireFly to focus on its Green Bay Copper-Gold Project [6][9]. Transaction Details - The total consideration includes upfront payment of 60 million Bellavista shares valued at A$47.4 million and contingent consideration of 50 million performance rights valued at A$38.7 million, based on Bellavista's closing share price of A$0.79 on January 30, 2026 [1][2][6]. - FireFly shareholders are expected to receive approximately 1 Bellavista share for every 12.8 FireFly shares held, subject to shareholder approval [6][20]. Strategic Rationale - The transaction is seen as a strategic move that allows FireFly shareholders to retain exposure to the Ontario Gold Assets through their shareholding in Bellavista while enabling FireFly to concentrate on the development of the Green Bay Copper-Gold Project [9][10]. - Bellavista is expected to leverage its dedicated exploration focus to create significant value from the acquired assets, which could lead to substantial growth for its shareholders, many of whom are also FireFly shareholders [5][10]. Management and Leadership - Bellavista is led by experienced executives Glenn Jardine and Peter Canterbury, who previously led De Grey Mining Ltd, indicating a strong management team capable of optimizing the value of the Ontario Gold Assets [10][33]. Milestones and Performance Rights - The contingent performance rights are structured in three tranches, with the first milestone expected to vest within 12 months of completion, potentially increasing FireFly's interest in Bellavista to no less than 9.9% [12][20]. - The milestones include drilling activities and resource estimates that, if achieved, will further enhance the value of the transaction for FireFly shareholders [12][13]. Financial Implications - The transaction is expected to provide FireFly with a simplified portfolio, reduced capital requirements, and minimized management distraction, while also allowing it to capitalize on the current strong gold price [11][9]. - Bellavista plans to raise approximately A$25 million to drive resource growth and a major exploration program at the Ontario Gold Assets [6][10].
BHP backs the next wave of exploration and technology talent in its biggest Xplor intake yet
Globenewswire· 2026-02-01 21:52
Core Insights - BHP has selected 10 early-stage exploration and technology companies for the 2026 BHP Xplor program, marking the largest cohort since the program's inception [1] - The 2026 cohort emphasizes a connected approach to early-stage exploration, integrating geological insight, data, and emerging technologies [2] - The program aims to enhance understanding of mineral systems in remote and complex environments through interdisciplinary collaboration [3] Exploration Companies - FrontierX (Canada) focuses on uranium exploration and is undertaking a preliminary project to test geological concepts [5] - Litchfield Minerals (Australia) is advancing copper, zinc, lead, silver, and gold opportunities, particularly in the Oonagalabi project [6] - Orion Minerals (South Africa) is applying modern data analytics to identify new discovery opportunities in its copper and zinc asset portfolio [7] - Otrera Resources (South America) is focused on sediment-hosted copper systems, leveraging regional experience and modern geochemical approaches [8] - PT GeoFix (Indonesia) is a geoscience consultancy applying proprietary tools to test new copper-gold exploration concepts [9] - Utah Geological Survey (USA) is leading a regional mineral systems analysis to improve understanding of mineral potential in the eastern Great Basin [10] Technology Companies - RadiXplore (Australia) uses AI to analyze historical exploration records and modern data for copper exploration [11] - Mineural (Canada) employs AI to help exploration teams identify and prioritize mineral targets more efficiently [12] - VectOres Science (USA) develops non-invasive tools to support mineral exploration, focusing on real-time data for early identification of mineral systems [13] - Discovery Genomics (Canada) is advancing DNA sequencing as a tool for mineral exploration, testing microbial DNA signatures to identify buried mineral systems [14]